Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
11.91
-0.09 (-0.75%)
At close: Jun 18, 2026, 4:00 PM EDT
11.95
+0.04 (0.34%)
After-hours: Jun 18, 2026, 5:19 PM EDT
Corvus Pharmaceuticals Employees
Corvus Pharmaceuticals had 37 employees as of December 31, 2025. The number of employees increased by 6 or 19.35% compared to the previous year.
Employees
37
Change (1Y)
6
Growth (1Y)
19.35%
Revenue / Employee
n/a
Profits / Employee
-$1,193,730
Market Cap
1.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 37 | 6 | 19.35% | 37 | 0 |
| Dec 31, 2024 | 31 | 3 | 10.71% | 31 | 0 |
| Dec 31, 2023 | 28 | -1 | -3.45% | 28 | 0 |
| Dec 31, 2022 | 29 | 1 | 3.57% | 29 | 0 |
| Dec 31, 2021 | 28 | -14 | -33.33% | 28 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Pharming Group | 407 |
| Xencor | 260 |
| EyePoint | 214 |
| DBV Technologies | 161 |
| ARS Pharmaceuticals | 159 |
| Absci | 140 |
| Jade Biosciences | 55 |
CRVS News
- 9 days ago - Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China - GlobeNewsWire
- 10 days ago - Corvus Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 15 days ago - Corvus Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 15 days ago - Corvus Pharmaceuticals Slides: FY 2026 - Filings
- 4 weeks ago - Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Corvus Pharmaceuticals Transcript: Study update - Transcripts
- 5 weeks ago - Corvus Pharmaceuticals Press release: Study update - Filings
- 5 weeks ago - Corvus Pharmaceuticals Slides: Study update - Filings